FDA Headquarters

FDA Guidance Offers Important REMS Definitions

A new guidance from the U.S. Food and Drug Administration (FDA) provides the agency’s latest thinking on how it defines the types of changes to approved risk evaluation and mitigation […]

Sanofi, Sites Find Ways to ‘Smile’ Together

Gatherings of representatives from clinical trial sponsors and sites aren’t always inspiring or uplifting, but don’t tell that to Victoria DiBiaso, from Clinical Sciences & Operations in Sanofi’s R&D organization. […]